Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cytozen is a proprietary Ayurvedic herbal formulation developed by Charak for the support of liver health and the treatment of various liver disorders. It is composed of a synergistic blend of traditional hepatoprotective and antioxidant herbs, including Katuki (*Picrorhiza kurroa*), Kalmegh (*Andrographis paniculata*), Punarnava (*Boerhavia diffusa*), Kumari (*Aloe barbadensis*), and Arogyavardhini Ras. Cytozen exhibits anti-inflammatory, antioxidant, and antiviral properties, helping to protect hepatic cells from oxidative stress, maintain balanced liver enzymes, and support natural detoxification. It is indicated for conditions such as alcoholic liver disease, drug-induced hepatotoxicity, chronic viral hepatitis, and fatty liver, and is available in capsule and syrup forms for oral administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cytozen.